Abstract:
Ayurvedic and traditional medical practitioners of Sri Lanka use the decoction of the immature in orescence of Cocos nucifera L.
(IC) variety aurantiaca for the treatment of menorrhagia. e progestogenic e ect of the ethyl acetate soluble proanthocyanidins
(EASPA) of the IC in female rats at a dose of 3.5mg/kg body weight has been reported. Acute and subacute toxicity studies of
EASPA of the IC carried out using female Wistar rats according to Organization for Economic Co‐operation and Development
(OECD) guidelines 423 and 407, respectively, are reported herein. In the acute toxicity study, a single dose of EASPA
(2000mg/kg body weight) was orally administered to rats, which were monitored for 14days. In the subacute toxicity study, rats were
orally administered with EASPA daily for 28days at doses of 1.75, 3.5, 7, and 14mg/kg body weight. No rat in either the acute or subacute
toxicity study exhibited mortality or clinical signs of toxicity. Further, these rats did not show any signicant change in their mean
body weight, food, and water intake, haematological and biochemical parameters as well as in the results of their histopathological
examinations compared to those of control group rats. According to results of the acute toxicity, the LD50 of EASPA is estimated to be
greater than 2000mg/kg body weight. Considering the results of the subacute toxicity study, the oral administration of EASPA daily
for 28days was well tolerated up to the dose, 14mg/kg by rats. ese results will be useful in the development of a novel therapeutic
agent from EASPA of the IC for the treatment of menorrhagia, which incapacitates a considerable proportion of women worldwide.
